Impact of Suvorexant on Sympathetic Nerve Activity and Baroreflex Function in Chronic Insomnia
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the effect of Suvorexant on sympathetic nerve activity and
baroreflex function in subject with chronic insomnia. The investigator's central hypothesis
is that Suvorexant will reduce sympathetic nerve activity and improve baroreflex function
when compared to placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Michigan Technological University Montana State University